Trials / Completed
CompletedNCT03248401
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
Effect of Cilostazol, a Phosphodiesterase 3 Inhibitor, on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the effect of cilostazol compared with aspirin on carotid atherosclerosis in patients with type 2 diabetes mellitus
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cilostazol | Cilostazol 200 mg/day |
| DRUG | Aspirin | Aspirin 100 mg/day |
Timeline
- Start date
- 2016-09-26
- Primary completion
- 2018-10-21
- Completion
- 2019-12-31
- First posted
- 2017-08-14
- Last updated
- 2020-04-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03248401. Inclusion in this directory is not an endorsement.